Trials / Completed
CompletedNCT00156143
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
GH Therapy in Partial GHD Adolescents : Evaluation of Efficacy Based on Body Composition and Comparison of 2 Different Doses of Genotonorm®. Open-Label, Randomised, Comparative, Controlled, Parallel-Group, Multi-Center Phase IIIB Clinical Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 15 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate in boys and girls the improvement in body composition under GH treatment in adolescents with CO-GHD who remain partially GHD after GH discontinuation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample | |
| PROCEDURE | Radiography |
Timeline
- Start date
- 2002-04-01
- Completion
- 2005-04-01
- First posted
- 2005-09-12
- Last updated
- 2007-07-30
Source: ClinicalTrials.gov record NCT00156143. Inclusion in this directory is not an endorsement.